IL129336A0 - Method for preparing compositions for transferring nucleic acids - Google Patents

Method for preparing compositions for transferring nucleic acids

Info

Publication number
IL129336A0
IL129336A0 IL12933697A IL12933697A IL129336A0 IL 129336 A0 IL129336 A0 IL 129336A0 IL 12933697 A IL12933697 A IL 12933697A IL 12933697 A IL12933697 A IL 12933697A IL 129336 A0 IL129336 A0 IL 129336A0
Authority
IL
Israel
Prior art keywords
nucleic acids
preparing compositions
transferring nucleic
transferring
compositions
Prior art date
Application number
IL12933697A
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of IL129336A0 publication Critical patent/IL129336A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6907Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Nanotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
IL12933697A 1996-10-08 1997-10-03 Method for preparing compositions for transferring nucleic acids IL129336A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9612259A FR2754272B1 (en) 1996-10-08 1996-10-08 PROCESS FOR THE PREPARATION OF COMPOSITIONS FOR TRANSFERRING NUCLEIC ACIDS
PCT/FR1997/001747 WO1998015639A1 (en) 1996-10-08 1997-10-03 Method for preparing compositions for transferring nucleic acids

Publications (1)

Publication Number Publication Date
IL129336A0 true IL129336A0 (en) 2000-02-17

Family

ID=9496468

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12933697A IL129336A0 (en) 1996-10-08 1997-10-03 Method for preparing compositions for transferring nucleic acids

Country Status (15)

Country Link
US (1) US6156338A (en)
EP (1) EP0948638A1 (en)
JP (1) JP2001501641A (en)
KR (1) KR20000048958A (en)
AU (1) AU723371B2 (en)
BR (1) BR9712210A (en)
CA (1) CA2267187A1 (en)
CZ (1) CZ119299A3 (en)
FR (1) FR2754272B1 (en)
HU (1) HUP9904579A3 (en)
IL (1) IL129336A0 (en)
NO (1) NO991383L (en)
SK (1) SK43199A3 (en)
WO (1) WO1998015639A1 (en)
ZA (1) ZA979031B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2750704B1 (en) 1996-07-04 1998-09-25 Rhone Poulenc Rorer Sa PROCESS FOR PRODUCING THERAPEUTIC DNA
AU2536299A (en) * 1998-02-17 1999-08-30 University Of Wales College Of Medicine Method and apparatus for introducing substances into the cell plasma membrane and/or cytosol
AU7542301A (en) * 2000-06-09 2001-12-17 Teni Boulikas Encapsulation of plasmid DNA (lipogenes<sup>TM</sup>) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
EP1513538A4 (en) * 2002-06-14 2007-08-22 Mirus Bio Corp Novel methods for the delivery of polynucleotides to cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873089A (en) * 1985-07-12 1989-10-10 Cornell Research Foundation Inc., Cornell University Proteoliposomes as drug carriers
JPS63277618A (en) * 1987-03-31 1988-11-15 Noebia:Kk Production of liposome
JPH03501732A (en) * 1987-12-22 1991-04-18 ザ リポソーム カンパニー,インコーポレイテッド Spontaneous vesiculation method for multilamellar liposomes
FR2714830B1 (en) * 1994-01-10 1996-03-22 Rhone Poulenc Rorer Sa Composition containing nucleic acids, preparation and uses.
FR2727679B1 (en) * 1994-12-05 1997-01-03 Rhone Poulenc Rorer Sa NEW TRANSFECTION AGENTS AND THEIR PHARMACEUTICAL APPLICATIONS

Also Published As

Publication number Publication date
FR2754272A1 (en) 1998-04-10
ZA979031B (en) 1998-04-23
CZ119299A3 (en) 1999-07-14
KR20000048958A (en) 2000-07-25
CA2267187A1 (en) 1998-04-16
SK43199A3 (en) 2000-04-10
NO991383D0 (en) 1999-03-22
AU4559197A (en) 1998-05-05
JP2001501641A (en) 2001-02-06
AU723371B2 (en) 2000-08-24
FR2754272B1 (en) 1998-11-13
US6156338A (en) 2000-12-05
BR9712210A (en) 1999-08-31
HUP9904579A3 (en) 2001-06-28
HUP9904579A2 (en) 2000-05-28
NO991383L (en) 1999-03-22
WO1998015639A1 (en) 1998-04-16
EP0948638A1 (en) 1999-10-13

Similar Documents

Publication Publication Date Title
IL127416A0 (en) Method for enhancing gene transfer
IL129761A0 (en) Method for preparing cyclopropylamines
IL166186A0 (en) Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
HK1023588A1 (en) Process for preparing an asphalt composition
GB9713283D0 (en) Method for preparing aminoalkoxysiloxanes
HUP0003905A3 (en) Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
HUP9904579A3 (en) Method for preparing compositions for transferring nucleic acids
HUP0004619A3 (en) Method for preparing formylphosphonic acid
HUP0003496A3 (en) Method for preparing oxazaphosphorin-2-amines
ZA9810859B (en) Process for preparing dialkylphosphinic acids.
IL134912A0 (en) Method for preparing 1-phenylpyrrazolin-3-carboxylic acid derivatives
EG21405A (en) Method for preparing phosphorique acid
ZA983777B (en) Method for preparing formylphosphonic acid
IL150954A (en) Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
HK1058030A1 (en) Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
SI1023279T1 (en) Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
AU3718997A (en) Method for preparing alpha-chloroboronic acids from mannitol
HUP9903883A3 (en) Method for preparing trimethylbenzoquinone
SI1032557T1 (en) Method for preparing bromomethyl-biphenyl derivatives